SCHEMBL24412751

SCHEMBL24412751

C=Cc1ccc(COCc2ccc(OCC3CO3)c(OC)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
MAPT P10636 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HTT P42858 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
DRD4 P21917 4/20 0.40
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
NPC1 O15118 6/20 0.38
RAB9A P51151 5/20 0.38
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PYGL P06737 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3833073 0.85 TRPA1 (0.46) ALDH1A1SMN1; SMN2DRD4TSHRTP53
SCHEMBL16923005 0.85 DRD4 (0.46) ALDH1A1SMN1; SMN2HTTDRD4TSHR
SCHEMBL24412749 0.83 MEN1 (0.44) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL21023624 0.83 DRD4 (0.44) ALDH1A1SMN1; SMN2HTTKDM4ELMNA
SCHEMBL9859946 0.80 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL24146971 0.80 DRD4 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2AHTT
SCHEMBL6631330 0.78 CA2 (0.49) ALDH1A1HTTKDM4EDRD4PPARG
SCHEMBL239227 0.78 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRTP53
SCHEMBL17857336 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL9859375 0.77 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4ELMNADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220145114-A1 OXIRANE-FUNCTIONAL VINYL MONOMERS AND METHODS FOR MAKING THE SAME SWIMC LLC 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220145114-A1 OXIRANE-FUNCTIONAL VINYL MONOMERS AND METHODS FOR MAKING THE SAME OXER1, APEH, OXGR1 ALDH1A1 91/4885SMN1; SMN2 3049/4885MAPT 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.